Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Olga Vondálová Blanářová"'
Autor:
Štěpán Čada, Olga Vondálová Blanářová, Kristína Gömoryová, Antónia Mikulová, Petra Bačovská, Nikodém Zezula, Alka Kumari Jadaun, Pavlína Janovská, Hana Plešingerová, Vítězslav Bryja
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
The migratory properties of leukemic cells are commonly associated with their pathological potential and can significantly affect the disease progression. While the research in immunopathology mostly employed powerful indirect methods such as flow cy
Externí odkaz:
https://doaj.org/article/fffa7f58808f4be6a911654bb32be784
Autor:
Zankruti Dave, Olga Vondálová Blanářová, Štěpán Čada, Pavlína Janovská, Nikodém Zezula, Martin Běhal, Kateřina Hanáková, Sri Ranjani Ganji, Pavel Krejci, Kristína Gömöryová, Helena Peschelová, Michal Šmída, Zbyněk Zdráhal, Šárka Pavlová, Jana Kotašková, Šárka Pospíšilová, Vítězslav Bryja
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) are malignancies characterized by the dependence on B-cell receptor (BCR) signaling and by the high expression of ROR1, the cell surface receptor for Wnt-5a. Both, BCR and ROR1 are the
Externí odkaz:
https://doaj.org/article/f859b8e261ed419caa9d076a1db931a2
Autor:
Tomasz Radaszkiewicz, Michaela Nosková, Kristína Gömöryová, Olga Vondálová Blanářová, Katarzyna Anna Radaszkiewicz, Markéta Picková, Ráchel Víchová, Tomáš Gybeľ, Karol Kaiser, Lucia Demková, Lucia Kučerová, Tomáš Bárta, David Potěšil, Zbyněk Zdráhal, Karel Souček, Vítězslav Bryja
Publikováno v:
eLife, Vol 10 (2021)
RNF43 is an E3 ubiquitin ligase and known negative regulator of WNT/β-catenin signaling. We demonstrate that RNF43 is also a regulator of noncanonical WNT5A-induced signaling in human cells. Analysis of the RNF43 interactome using BioID and immunopr
Externí odkaz:
https://doaj.org/article/429690658a42429e81ef4cee4109bc0b
Autor:
Jarmila Herůdková, Kamil Paruch, Prashant Khirsariya, Karel Souček, Martin Krkoška, Olga Vondálová Blanářová, Petr Sova, Alois Kozubík, Alena Hyršlová Vaculová
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 19, Iss 10, Pp 830-841 (2017)
Although Chk1 kinase inhibitors are currently under clinical investigation as effective cancer cell sensitizers to the cytotoxic effects of numerous chemotherapeutics, there is still a considerable uncertainty regarding their role in modulation of an
Externí odkaz:
https://doaj.org/article/e81b0f5a2c1d4cceb65c2243075f3a24
Autor:
Olga Vondálová Blanářová, Barbora Šafaříková, Jarmila Herůdková, Martin Krkoška, Silvie Tománková, Zuzana Kahounová, Ladislav Anděra, Jan Bouchal, Gvantsa Kharaishvili, Milan Král, Petr Sova, Alois Kozubík, Alena Hyršlová Vaculová
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188584 (2017)
Searching for new strategies for effective elimination of human prostate cancer cells, we investigated the cooperative cytotoxic action of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and two platinum-based complexes, cisplatin or
Externí odkaz:
https://doaj.org/article/f28d4460e94e49e89d81127c542aa443
Autor:
Karol Kaiser, Katarzyna Anna Radaszkiewicz, Markéta Pícková, Tomasz Witold Radaszkiewicz, Michaela Nosková, Vítězslav Bryja, David Potěšil, Olga Vondálová Blanářová, Kristína Gömöryová, Lucia Kucerova, Karel Souček, Tomáš Gybeľ, Lucia Demkova, Zbyněk Zdráhal, Tomáš Bárta, Ráchel Víchová
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::905768284c397fa6efa2260754aa2cc6
https://doi.org/10.7554/elife.65759.sa2
https://doi.org/10.7554/elife.65759.sa2
Autor:
Zbyněk Zdráhal, Olga Vondálová Blanářová, Tomáš Gybeľ, Markéta Pícková, Lucia Kucerova, Ráchel Víchová, Kristína Gömöryová, Tomasz Witold Radaszkiewicz, Karol Kaiser, Vítězslav Bryja, David Potěšil, Tomáš Bárta, Michaela Nosková, Karel Souček, Lucia Demkova, Katarzyna Anna Radaszkiewicz
Publikováno v:
eLife
eLife, Vol 10 (2021)
eLife, Vol 10 (2021)
RNF43 is an E3 ubiquitin ligase and known negative regulator of WNT/β-catenin signaling. We demonstrate that RNF43 is also a regulator of noncanonical WNT5A-induced signaling in human cells. Analysis of the RNF43 interactome using BioID and immunopr
Autor:
Olga Vondálová Blanářová, Petra Lesáková, Petr Humpolíček, Lucie Woloszczuková, Lukáš Kubala, Tomasz Witold Radaszkiewicz, Deborah Beckerová, Jiří Pacherník, Katarzyna Anna Radaszkiewicz
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
12-O-Tetradecanoylphorbol-13-acetate (TPA) is the most widely used diacylglycerol (DAG) mimetic agent and inducer of protein kinase C (PKC)-mediated cellular response in biomedical studies. TPA has been proposed as a pluripotent cell differentiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89de8541babb3f730db685c2ed215fd6
http://publikace.k.utb.cz/handle/10563/1009938
http://publikace.k.utb.cz/handle/10563/1009938
Autor:
Ladislav Anděra, Alena Hyršlová Vaculová, Silvie Tománková, Jan Bouchal, Milan Král, Martin Krkoška, Petr Sova, Zuzana Kahounová, Barbora Šafaříková, Gvantsa Kharaishvili, Alois Kozubík, Olga Vondálová Blanářová, Jarmila Herůdková
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 11, p e0188584 (2017)
PLoS ONE, Vol 12, Iss 11, p e0188584 (2017)
Searching for new strategies for effective elimination of human prostate cancer cells, we investigated the cooperative cytotoxic action of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and two platinum-based complexes, cisplatin or
Autor:
János Szöllősi, Viktor Horváth, Jiřina Hofmanová, Alois Kozubík, Ladislav Anděra, Alena Hyršlová Vaculová, György Vereb, Petr Sova, Olga Vondálová Blanářová, Karel Souček, Árpád Szöőr, Belma Skender, Iva Jelínková
Publikováno v:
Carcinogenesis. 32:42-51
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) can selectively trigger apoptosis in various cancer cell types. However, many cancer cells are resistant to death receptor-mediated apoptosis. Combination therapy with platinum complexes